Antithrombotic use patterns for secondary stroke prevention in ischemic stroke patients with active malignancy: The STOP-SPAM study.
BACKGROUND Cancer-associated stroke is increasingly recognized as a distinct ischemic stroke subtype linked to malignancy-related hypercoagulability. Optimal secondary prevention is uncertain, and antithrombotic practice varies. We examined treatment patterns and compared outcomes of anticoagulation versus antiplatelet...